We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+2.18%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$862M
AUM Growth
+$115M
Cap. Flow
+$101M
Cap. Flow %
11.69%
Top 10 Hldgs %
40.55%
Holding
227
New
21
Increased
66
Reduced
87
Closed
20

Sector Composition

Rank Sector Weight
1 Technology 11.69%
2 Healthcare 7.01%
3 Consumer Discretionary 5.84%
4 Industrials 5.45%
5 Communication Services 3.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
76
DELISTED
Allergan plc
AGN
$2.61M 0.3%
12,425
-8,848
-42% -$1.83M
SUB icon
77
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
$2.54M 0.29%
24,156
SCHO icon
78
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
$2.36M 0.27%
+93,690
New +$2.37M
TM icon
79
Toyota
TM
$227B
$2.34M 0.27%
19,933
-359
-2% -$41.8K
WU icon
80
Western Union
WU
$2.4B
$2.34M 0.27%
107,531
-4,890
-4% -$101K
F icon
81
Ford
F
$59.3B
$2.05M 0.24%
169,018
-11,444
-6% -$139K
TROW icon
82
T. Rowe Price
TROW
$25.6B
$2.03M 0.24%
26,919
-871
-3% -$61.7K
MMM icon
83
3M
MMM
$90.8B
$1.97M 0.23%
13,205
+39
+0.3% +$5.63K
IYM icon
84
iShares US Basic Materials ETF
IYM
$1.15B
$1.97M 0.23%
23,632
+6,094
+35% +$493K
TDC icon
85
Teradata
TDC
$2.88B
$1.92M 0.22%
70,571
-23,224
-25% -$655K
NTAP icon
86
NetApp
NTAP
$34.1B
$1.9M 0.22%
53,838
-1,788
-3% -$62.6K
PFE icon
87
Pfizer
PFE
$142B
$1.9M 0.22%
61,603
+7,770
+14% +$237K
SCHX icon
88
Schwab US Large- Cap ETF
SCHX
$71.3B
$1.86M 0.22%
209,874
+7,434
+4% +$64.6K
BT
89
DELISTED
BT Group plc (ADR)
BT
$1.8M 0.21%
78,079
+1,103
+1% +$25.5K
SCHM icon
90
Schwab US Mid-Cap ETF
SCHM
$14.5B
$1.79M 0.21%
119,301
+1,158
+1% +$16.9K
TD icon
91
Toronto Dominion Bank
TD
$198B
$1.76M 0.2%
35,670
-752
-2% -$35.1K
TT icon
92
Trane Technologies
TT
$97.3B
$1.63M 0.19%
22,479
SCHA icon
93
Schwab U.S Small- Cap ETF
SCHA
$22.3B
$1.55M 0.18%
101,040
+828
+0.8% +$12.2K
EEM icon
94
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$1.46M 0.17%
41,731
-161,664
-79% -$5.83M
TEVA icon
95
Teva Pharmaceuticals
TEVA
$41.2B
$1.42M 0.16%
39,188
-683
-2% -$27.3K
PG icon
96
Procter & Gamble
PG
$335B
$1.41M 0.16%
16,745
-537
-3% -$45.8K
MCD icon
97
McDonald's
MCD
$191B
$1.38M 0.16%
11,305
-109
-1% -$12.8K
USB icon
98
US Bancorp
USB
$98B
$1.34M 0.16%
26,128
-2,856
-10% -$136K
PEP icon
99
PepsiCo
PEP
$191B
$1.3M 0.15%
12,397
+745
+6% +$78K
SPGP icon
100
Invesco S&P 500 GARP ETF
SPGP
$2.25B
$1.26M 0.15%
37,608
-39,313
-51% -$1.32M

Similar funds

Grimes & Company's Q4 2016 Portfolio in Review

As of Q4 2016, Grimes & Company held 227 positions worth $862M, up 15% from $747M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Grimes & Company deployed $101M of net new capital in Q4 2016, opening 21 new positions and adding to 66 existing holdings. Its largest new stake was State Street SPDR Bloomberg High Yield Bond ETF: 400,658 shares worth $43.8M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $18.7M trimmed.

  • Grimes & Company's largest Q4 2016 buy was State Street SPDR Bloomberg High Yield Bond ETF: 400,658 shares worth $43.8M.
  • Grimes & Company added most to iShares 1-3 Year Treasury Bond ETF in Q4 2016, an estimated $36.4M increase.
  • Grimes & Company's biggest Q4 2016 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $18.7M.
  • Grimes & Company fully exited VanEck High Yield Muni ETF in Q4 2016, selling an estimated $24.2M.
  • Grimes & Company's ten largest holdings make up 41% of its $862M portfolio in Q4 2016.
  • Grimes & Company opened 21 new positions and closed 20 in Q4 2016.
  • Grimes & Company's portfolio value rose 15% quarter-over-quarter to $862M.

Based on Grimes & Company's 13F filing for Q4 2016, filed 24 Jan 2017.